These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 398989)

  • 21. Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species.
    Whittle BJ; Moncada S; Vane JR
    Prostaglandins; 1978 Sep; 16(3):373-88. PubMed ID: 364545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostacyclin produced by the pregnant uterus in the dog may act as a circulating vasodepressor substance.
    Gerber JG; Payne NA; Murphy RC; Nies AS
    J Clin Invest; 1981 Mar; 67(3):632-6. PubMed ID: 7009646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet and cardiovascular activity of the hydantoin BW245C, a potent prostaglandin analogue.
    Whittle BJ; Moncada S; Mullane K; Vane JR
    Prostaglandins; 1983 Feb; 25(2):205-23. PubMed ID: 6344147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostacyclin (PGI2) elicits reflex bradycardia in dogs: evidence for vagal mediation.
    Hintze TH; Martin EG; Messina EJ; Kaley G
    Proc Soc Exp Biol Med; 1979 Oct; 162(1):96-100. PubMed ID: 388455
    [No Abstract]   [Full Text] [Related]  

  • 25. Renin release from filtering and nonfiltering kidneys stimulated by PGI2 and PGD2.
    Seymour AA; Davis JO; Freeman RH; DeForrest JM; Rowe BP; Williams GM
    Am J Physiol; 1979 Oct; 237(4):F285-90. PubMed ID: 386806
    [No Abstract]   [Full Text] [Related]  

  • 26. Topical prostacyclin (PGI2) inhibits platelet aggregation in pial venules of the mouse.
    Rosenblum WI; El-Sabban F
    Stroke; 1979; 10(4):399-401. PubMed ID: 388737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemodynamic responses to prostacyclin (PGI2) in the conscious sheep.
    Kubo K; Kobayashi T; Yoshimura K; Fukushima M; Handa K; Kusama S; Sakai A; Ueda G
    Jpn Circ J; 1982 Dec; 46(12):1292-304. PubMed ID: 6754986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The stimulatory effect of prostacyclin (PGI2) on isolated rabbit and rat aorta is probably associated to the generation of a thromboxane A2 (TXA2) "like-material".
    Borda ES; Sterin-Borda L; Gimeno MF; Lazzari MA; Gimeno AL
    Arch Int Pharmacodyn Ther; 1983 Jan; 261(1):79-89. PubMed ID: 6342559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet preservation during cardiopulmonary bypass (CPB) with prostaglandin (PGE1) and prostacyclin (PGI2).
    van den Dungen JJ; Velders AJ; Karliczek GF; Homan van der Heide JN; Wildevuur CR
    Trans Am Soc Artif Intern Organs; 1980; 26():481-6. PubMed ID: 7018057
    [No Abstract]   [Full Text] [Related]  

  • 30. Changes of mean arterial pressure of the rat resulting from intracerebroventricular injections of prostacyclin or 6-keto-prostaglandin F1 alpha.
    Kenney NJ
    Prostaglandins; 1983 Mar; 25(3):335-42. PubMed ID: 6346396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of epoprostenol (prostacyclin, PGI2) on cerebral blood flow in man.
    Brown MM; Pickles H
    J Neurol Neurosurg Psychiatry; 1982 Nov; 45(11):1033-6. PubMed ID: 6816907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of intravenous infusion of prostacyclin (PGI2) in man.
    O'Grady J; Warrington S; Moti MJ; Bunting S; Flower R; Fowle AS; Higgs EA; Moncada S
    Prostaglandins; 1980 Feb; 19(2):319-32. PubMed ID: 6992228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Central cardiovascular effects of prostacyclin.
    Feuerstein G; Adelberg S; Kopin IJ; Jacobowitz DM
    Neuropharmacology; 1981 Nov; 20(11):1085-90. PubMed ID: 7033813
    [No Abstract]   [Full Text] [Related]  

  • 34. Vascular relaxing activity and stability studies of 10,10-difluoro-13,14-dehydroprostacyclin.
    Hatano Y; Kohli JD; Goldberg LI; Fried J; Mehrotra MM
    Proc Natl Acad Sci U S A; 1980 Nov; 77(11):6846-50. PubMed ID: 7005902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Action of prostacyclin (PGI2) and prostaglandin E2 (PGE2) on gastric secretion and mucosal blood flow in dogs.
    Konturek SJ
    Gastroenterology; 1980 Jul; 79(1):182-4. PubMed ID: 6991360
    [No Abstract]   [Full Text] [Related]  

  • 36. Anti-aggregatory effect of prostacyclin (PGI2) in vivo.
    Bayer BL; Blass KE; Förster W
    Br J Pharmacol; 1979 May; 66(1):10-2. PubMed ID: 378308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous administration of prostacyclin in rabbits: elimination kinetics and blood pressure response.
    Skrinska VA; Lucas FV; Chisolm GM; Hesse BL
    J Lab Clin Med; 1986 Mar; 107(3):187-93. PubMed ID: 3512745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison in anesthetized dogs of the anti-aggregatory and hemodynamic effects of prostacyclin and a chemically stable prostacyclin analog, 6a-carba-PGI2 (carbacyclin).
    Aiken JW; Shebuski RJ
    Prostaglandins; 1980 Apr; 19(4):629-43. PubMed ID: 6992235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The renal haemodynamic and excretory actions of prostacyclin (PGI2) in anaesthetized dogs [proceedings].
    Hill TW; Moncada S
    Br J Pharmacol; 1978 Mar; 62(3):413P-414P. PubMed ID: 346131
    [No Abstract]   [Full Text] [Related]  

  • 40. Prostacyclin--antiarrhythmic or arrhythmogenic? Comparison of the effects of intravenous and intracoronary prostacyclin and ZK36374 during coronary artery occlusion and reperfusion in anaesthetised greyhounds.
    Coker SJ; Parratt JR
    J Cardiovasc Pharmacol; 1983; 5(4):557-67. PubMed ID: 6193351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.